A clinical-stage biotechnology company focused on developing therapies for kidney disease, with an initial emphasis on ...
This is a schematic depiction of how an early metabolism could have expanded from an initial set of prebiotic molecules, with thioester (S) vs. phosphate (P) as the main driving force. Disclaimer: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results